Kiniksa Pharmaceuticals shareholders waive conversion rights in new deed

Baker Bros. Advisors LP, on behalf of Kiniksa shareholders, has irrevocably waived all conversion rights for certain share classes under a deed executed May 21, 2026. The waiver simplifies the company's capital structure and eliminates potential share conversion flexibility for major investors.